FHIR Clinical Guidelines (v1.0.0) (STU1)

This page is part of the Clinical Guidelines (v1.0.0: STU 1) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions

MedicationAdministration-chf-scenario1-lasix-iv

Formats: XML, JSON, Turtle

Generated Narrative

status: completed

medication: LASIX IV

subject: Generated Summary: active; Patterson, Jeremy; gender: male; birthDate: 1949-03-17;

effective: Feb 3, 2019 7:08:00 AM

Dosages

-TextRouteDose
*40mgIntravenous Route (qualifier value)40 mg